Andre forklaringer, som ikke udnævner plasma FFA - reduktioner som central drivkraft for modificering af lipidprofilen, omfatter nicotinsyremedieret hæmning af de novo- lipogenese eller esterificering af fedtsyrer til TG i leveren.
Additional explanations that do not invoke plasma FFA reduction as the central driver of lipid profile modification include nicotinic acid-mediated inhibition of de novo lipogenesis or esterification of fatty acids into TG in the liver.